CMTM6 maintains B cell-intrinsic CD40 expression to regulate anti-tumor immunity

Yiru Long,Runqiu Chen,Wenlong Chang,Hanyue Luo,Fanglin Li,Jianhua Sun,Jing Chen,Likun Gong

DOI: https://doi.org/10.1101/2024.03.05.583639

2024-03-10

Abstract:Tumor cell CMTM6 is a novel tumor immunoregulator involved in maintaining membrane levels of several important molecules, such as PD-L1 and CD58. Host CMTM6 may also play a function in the tumor microenvironment. Here, we found that CMTM6 was highly expressed in splenic B cells and tumor-infiltrating B cells. CMTM6 deficiency resulted in impaired splenic development, germinal center B cell differentiation, memory B cell differentiation, and B cell anti-tumor immune responses. Through multi-omics data mining and B-cell agonist screening, we identified that CMTM6 interacted with CD40 and maintained CD40 membrane levels in B cells. CMTM6 regulated CD40 at the post-translational modification stage but not at the transcriptional stage. CMTM6 deficiency led to impaired CD40 signaling-mediated B cell activation, survival, proliferation, and differentiation. In vivo, CMTM6 deficiency leads to a significant decrease in the anti-tumor activity of B cell-dependent CD40 agonists. Collectively, B-cell intrinsic CMTM6 maintains B cell CD40 levels and signaling to promote B cell function and anti-tumor immunity.

Immunology

What problem does this paper attempt to address?

The paper attempts to address the issue of exploring the expression of CMTM6 in B cells and its impact on the anti-tumor immune function of B cells. Specifically, the researchers aim to answer this question through the following points:

1. **The role of B cells in anti-tumor immunity**:
- The researchers first verified the importance of B cells in the tumor microenvironment (TME) and found that B cells can promote T cell infiltration and function, thereby enhancing the anti-tumor immune response.

2. **Expression of CMTM6 in B cells**:
- Through single-cell sequencing data and flow cytometry, the researchers found that CMTM6 is highly expressed in peripheral blood and tumor-infiltrating B cells, suggesting that it may play an important role in B cells.

3. **Impact of CMTM6 on B cell differentiation and function**:
- Using a CMTM6 knockout mouse model, the researchers found that CMTM6 deficiency leads to impaired B cell differentiation, particularly a significant reduction in the number of memory B cells and germinal center B cells.

4. **Interaction between CMTM6 and CD40**:
- The researchers discovered that CMTM6 regulates the CD40 signaling pathway by maintaining the level of CD40 on the surface of B cells, thereby affecting B cell activation, survival, proliferation, and differentiation.

5. **Impact of CMTM6 on the anti-tumor effect of CD40 agonists**:
- The researchers further found that CMTM6 deficiency significantly reduces the anti-tumor effect of CD40 agonists, indicating the critical role of CMTM6 in B cell-mediated anti-tumor immunity.

In summary, this paper aims to elucidate how CMTM6 regulates B cell function and anti-tumor immune response by maintaining the level of CD40 on the surface of B cells, and the important role of CMTM6 in intrinsic B cell immunity. These findings help deepen the understanding of B cells in tumor immunotherapy and provide a theoretical basis for developing new therapeutic strategies.